EQT to buy diagnostics player Qiagen for €9.6bn
EQT Private Equity has agreed to acquire German-Dutch molecular testing company Qiagen for €9.6bn ($10.7bn), reflecting the public market’s increasing…
All articles by Annabel Kartal Allen
Annabel Kartal Allen
Annabel Kartal-Allen is a reporter for Clinical Trials Arena, Pharmaceutical Technology and Medical Device Network based in London, UK. Annabel holds interests in oncology, neurology and metabolic diseases. She has previous experience reporting for both the pharmaceutical and nutraceutical industries, and holds a BSc in Biology from the University of Sussex. Contact Annabel
-
-
MHRA homes in on personalised healthcare and tech in new 2030 strategy
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has devised a new strategy to better harness advancements in personalised…
-
Steris outlays $2.1bn to acquire Xodus Medical
Steris has penned a deal to acquire surgical safety solutions developer, Xodus Medical, for $2.1bn – adding a range of…
-
Scarlet nabs $50m to grow AI-native medtech certification platform
Artificial intelligence (AI) and software-based medical device-centric company, Scarlet, has banked $50m in a Series B round to expand the…
-
MMI pockets $125m to back its robotic microsurgery’s market growth
Florida-based robotics specialist, MMI, has banked $125m in a Series D funding round, financially fortifying the company as it looks to…
-
Eye implant sight improvements in GA continue for 36 months, pivotal study finds
Science Corporation’s subretinal implant and specialised glasses combination, PRIMA, has been shown to provide durable, long-term gains in vision to…
-
UK government backs healthcare commission blueprint for AI-enabled devices
The UK government has opted to accept all the recommendations made by its specialist healthcare-focused artificial intelligence (AI) commission around…
-
Brainomix’s e-Lung shows progression and treatment response in Phase III trial
Brainomix has debuted data from a Phase III progressive pulmonary fibrosis (PPF) study that highlights the ability of its artificial…
-
Podcast: Continuous monitoring’s burgeoning role in metabolic health
In recent years, the way many patients manage their diabetes has undergone a fundamental shift, with the role of wearables…
-
Patients want flexible and involved cardiac care, but cost hurdles remain
A new survey from digital health company Vivalink has found that patients with cardiac conditions favour flexible-home based cardiac rehabilitation…